Skip to main content
. 2019 Nov 29;19:643–653. doi: 10.1016/j.omtn.2019.10.047

Figure 4.

Figure 4

Knockdown of UCA1 Enhances Gefitinib Sensitivity In Vivo

(A) The tumor volume curve of nude mice was analyzed. (B) The tumor weights of nude mice were measured. (C) sh-UCA1 plus gefitinib decreased the percentage of proliferating Ki67-positive cells compared with the LV-NC plus gefitinib group. **p < 0.01.